Charles Moore has a long-proven track record in both print and digital journalism, touching on a wide range of subjects, from biotech and healthcare to politics and technology. He contributes substantial feature articles research and development for the news site, particularly pertaining to technology.
The U.S. Food and Drug Administration (FDA) has granted clinical stage biotechnology company Advaxis special approval for a Phase 3 clinical trial to evaluate the safety and effectiveness of the company’s lead ... Read more
With more than 500,000 new patients diagnosed every year and 250.000 deaths recorded annually, cervical cancer is the second most common cancer among women worldwide and approximately 70 percent of ... Read more
Dublin-based market analysis firm Research and Markets has announced the release of a major new 70 page report: “Global HPV Testing Market 2015-2019,” projecting that the global Human Papilloma Virus ... Read more